ASPEN NEUROSCIENCE, INC. (ASPE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-09
7:28 pm
Purchase
2026-11-0213DASPEON INC
ASPE
ARCH Venture Fund X, L.P.3,754,922
12.900%
3,754,922increase
(New Position)
Filing
History
2026-11-09
4:43 pm
Purchase
2026-11-0213GASPEON INC
ASPE
Frazier Life Sciences X, L.P.1,674,321
5.800%
1,674,321increase
(New Position)
Filing
History
2026-11-06
6:38 pm
Purchase
2026-11-0213DASPEON INC
ASPE
ORBIMED ADVISORS LLC3,589,132
12.300%
3,589,132increase
(New Position)
Filing
History
2026-11-06
5:34 pm
Purchase
2026-10-3013GASPEON INC
ASPE
GILEAD SCIENCES INC.
GILD
2,879,996
9.900%
2,879,996increase
(New Position)
Filing
History
2026-11-06
09:45 am
Purchase
2026-10-3013GASPEON INC
ASPE
FMR LLC3,250,000
11.200%
3,250,000increase
(New Position)
Filing
History
2026-11-03
09:17 am
Purchase
2026-10-3013GASPEON INC
ASPE
Qatar Investment Authority1,933,330
6.700%
1,933,330increase
(New Position)
Filing
History